Beijing, China

Dongyun Hao

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Amsinomed Medical Co., Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongyun Hao. Retrieved from https://idiyas.com/inventor/dongyun-hao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Dongyun Hao in Vascular Stent Technology

Introduction

Dongyun Hao is a prominent inventor based in Beijing, China, known for his significant contributions to the field of biomedical engineering. He holds 2 patents that focus on advanced vascular stent technologies, which aim to improve patient outcomes in cardiovascular treatments.

Latest Patents

His latest patents include a cobalt-chromium alloy stent and a drug-eluting stent. The cobalt-chromium alloy stent comprises several main body units, each made up of supporting rings connected by flexible ribs. The adjacent main body units are linked by connecting ribs. This innovative design enhances the stent's performance in vascular applications. The drug-eluting stent incorporates a drug coating containing arsenic trioxide and tacrolimus. The drug release curves of these composite drugs are adjusted to effectively inhibit the inflammatory response of vascular endothelial cells and the proliferation behavior of vascular smooth muscle cells, thereby reducing the vascular restenosis rate.

Another notable patent is the degradable biomedical magnesium alloy drug-eluting vascular stent and its preparation method. This stent is designed with a magnesium alloy that includes specific components such as Gd, Y, Li, Zn, and Zr, ensuring good radial support strength and strain dispersion capability. The use of a protective coating significantly improves the corrosion resistance of the magnesium alloy stent. Additionally, an arsenic trioxide/rapamycin and tacrolimus composite drug sustained-release system is employed to adapt to the damage repair process of blood vessels. The implantation results in large animals demonstrate that this vascular stent system has a favorable anti-restenosis treatment effect.

Career Highlights

Dongyun Hao is currently associated with Amsinomed Medical Co., Ltd., where he continues to innovate in the field of medical devices. His work has garnered attention for its potential to enhance the effectiveness of vascular interventions.

Collaborations

He collaborates with talented coworkers, including Xin Shen and Fugui He, who contribute to the development of cutting-edge medical technologies.

Conclusion

Dongyun Hao's innovative work in vascular stent technology showcases his commitment to improving healthcare solutions. His patents reflect a deep understanding of biomedical engineering and a dedication to advancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…